Anesthetic Management in A Patient with Untreated Type L Neurofibromatosis and Left Tibial Fracture: A Clinical Case Report

Main Article Content

Lizbeth malaga antonio
Edgar Efraín Hernández Luna
Enedina Madrazo Pérez

Abstract

Neurofibromatosis type I (NF1) is a multisystemic genetic disorder that poses significant anesthetic challenges, particularly in undiagnosed patients and emergency settings1.This report presents the case of a male patient with cognitive disability and no prior surgical or formal NF1 diagnosis, admitted due to a distal tibial fracture 2. During the preoperative evaluation, clinical signs suggestive of NF1—such as café-au-lait spots, dermal neurofibromas, and Lisch nodules—were identified and confirmed by Internal Medicine3. Given a potentially difficult airway (Mallampati III, IPID 8), spinal anesthesia was chosen, using ropivacaine and fentanyl. The procedure was successful, with no hemodynamic or neurological complications 4.


This case highlights the importance of thorough preoperative assessment and individualized anesthetic planning based on patient-specific risks 5. It also highlights the safety of neuraxial approaches in NF1 patients when no structural contraindications are evident. This experience contributes to the medical literature by documenting a safe and effective alternative in scenarios with diagnostic uncertainty and elevated anesthetic risk.

Article Details

How to Cite
malaga antonio, Lizbeth, Edgar Efraín Hernández Luna, and Enedina Madrazo Pérez. 2026. “Anesthetic Management in A Patient With Untreated Type L Neurofibromatosis and Left Tibial Fracture: A Clinical Case Report”. International Journal of Medical Science and Clinical Research Studies 6 (02):404-6. https://doi.org/10.47191/ijmscrs/v6-i2-28.
Section
Articles

References

Patel KR, Verma S. Anesthetic considerations in neurofibromatosis type 1: a comprehensive review. J Anesthesiol Clin Sci. 2022;10(2):45-51.

Thompson RT, Miller JG. Anesthetic management of undiagnosed neurofibromatosis type I: A case report and review of anesthetic concerns. Case Rep Anesthesiol. 2019:1-5.

Statement of the National Institutes of Health Consensus Conference on Neurofibromatosis. Arch Neurol. 1988;45(5):575-8.

D'Mello A, Lee SK. Safety and efficacy of neuraxial anesthesia in patients with neurofibromatosis. Anesth Analg. 2021;133(4):1021-9.

American Society of Anesthesiologists. Practice guidelines for preanesthetic evaluation: Updated report of the American Society of Anesthesiologists Preanesthetic Evaluation Task Force. Anesthesiology. 2020;132(5):e120-37.

Calva Maldonado M, Zepeda Olivera S, Pablo Yáñez JC, Fragoso Avilés F. Anesthetic management in Von Recklinghausen's disease. A case report. Rev Chil Anest. 2018;47:37-9. doi:10.25237/revchilanestv47n01.

Guerrero-Domínguez R, López-Herrera-Rodríguez D, Acosta-Martínez J, Jiménez I. Anesthetic implications in Von Recklinghausen's disease. Rev Colomb Anestesiol. 2015;43(1):107–10. doi:10.1016/j.rca.2014.08.002